UPDATE: Goldman Sachs Raises PT to $16 on NuVasive

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Goldman Sachs raises its price target $2 to $16 on Neutral-rated NuVasive (NASDAQ: NUVA) as the company continues to execute in what is an increasingly difficult end-user market. Goldman Sachs says, "4Q2011 results showed market share acceleration in the base US Spine business, as share gains and conversion to minimally invasive surgical (MIS) procedures are still positive trends. In 2012, management's guidance assumes that the base organic growth rate decelerates 300bp (US decelerating 400bp), which we think is appropriately conservative as it relates to end-market trends."NUVA closed at $15.55 a share yesterday.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!